Motley Fool Wealth Management LLC Sells 2,274 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Motley Fool Wealth Management LLC lessened its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 1.6% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 141,135 shares of the company’s stock after selling 2,274 shares during the period. Motley Fool Wealth Management LLC owned 0.16% of HealthEquity worth $11,552,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. International Assets Investment Management LLC acquired a new position in shares of HealthEquity during the second quarter valued at about $35,000. Paladin Wealth LLC bought a new position in HealthEquity in the third quarter worth approximately $39,000. GAMMA Investing LLC grew its stake in HealthEquity by 114.8% in the second quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock valued at $51,000 after acquiring an additional 318 shares during the period. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of HealthEquity during the second quarter valued at approximately $73,000. Finally, 1620 Investment Advisors Inc. acquired a new position in shares of HealthEquity during the third quarter worth approximately $112,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Stock Performance

HealthEquity stock opened at $101.39 on Wednesday. The firm’s 50 day simple moving average is $91.07 and its 200 day simple moving average is $83.17. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 1-year low of $62.10 and a 1-year high of $105.82. The firm has a market capitalization of $8.85 billion, a PE ratio of 84.49, a price-to-earnings-growth ratio of 1.59 and a beta of 0.55.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, topping analysts’ consensus estimates of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The firm had revenue of $299.93 million for the quarter, compared to analyst estimates of $284.48 million. As a group, analysts expect that HealthEquity, Inc. will post 2.27 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the sale, the director now owns 54,719 shares of the company’s stock, valued at $4,540,582.62. This trade represents a 13.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Frank Corvino sold 1,039 shares of the business’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total transaction of $99,847.90. Following the transaction, the director now directly owns 3,784 shares in the company, valued at approximately $363,642.40. The trade was a 21.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 10,536 shares of company stock valued at $884,517. Corporate insiders own 2.20% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on HQY. The Goldman Sachs Group started coverage on shares of HealthEquity in a report on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price on the stock. Barrington Research raised their target price on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a report on Monday. Royal Bank of Canada reiterated an “outperform” rating and set a $92.00 price target on shares of HealthEquity in a report on Wednesday, September 4th. BTIG Research raised their price objective on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $105.00 price objective on shares of HealthEquity in a report on Wednesday, September 4th. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $108.38.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.